These results not only clarified how ZKSCAN3 facilitates cervical cancer advancement through the coordination of proliferation, metastasis, and alterations in the tumor microenvironment, but also offered experimental support for its use as a prognostic biomarker and potential therapeutic target [77]. The gene discussed is ZKSCAN3; the disease is neoplasm.